Rocket Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -2.83%
- Market cap
- $267.98M
- 111.66M shares
- Filings
- 978
Q3 2026
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−52.6% FY25 yoy
- $267.98M
- —
- —
- 0.8×
- -59.42%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2021 | — | $0.00 | $0.00 | — | 64.51M sh | +4.4% | — |
| FY2020 | — | $72.00K | $72.00K | — | 61.78M sh | +12.2% | — |
| FY2019 | — | $0.00 | $0.00 | — | 55.07M sh | +22.1% | — |
| FY2018 | — | $0.00 | $0.00 | — | 45.11M sh | +14.5% | — |
| FY2017 | — | $0.00 | $0.00 | — | 39.40M sh | +46.0% | — |
Pharmaceutical preparations
Rocket Pharmaceuticals, Inc. is the 231st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PREPrenetics Global LtdFiscal 2024 figures———$282.0MPRLDPrelude Therapeutics Inc$12.1M73.4%819.6%$281.8MINOInovio Pharmaceuticals, Inc.$65.3K70.0%130,000.0%$274.4MFTHFaeth Therapeutics, Inc.———$272.4M
RCKTRocket Pharmaceuticals, Inc. (this company)$0.0——$268.0M
QTTBQ32 Bio Inc.$53.7M—55.5%$263.3MBIOABioAge Labs, Inc.$9.0M—896.1%$260.1MLABStandard Biotools Inc.$85.3M6.2%87.8%$257.9MCAMPCamp4 Therapeutics Corp$3.5M436.5%2,298.5%$254.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR